These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Assessment of cardiac rejection following heart and lung transplantation (I)]. Hachida M; Kurosawa H; Koide M; Koyanagi H Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2250-5. PubMed ID: 2614105 [TBL] [Abstract][Full Text] [Related]
15. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation. Bouchard D; Despatis MA; Buluran J; Cartier R Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of thalidomide as immunosuppressor in heterotopic heart transplantation. de Carvalho JB; Petroianu A; Alberti LR Chirurgia (Bucur); 2008; 103(4):429-34. PubMed ID: 18780616 [TBL] [Abstract][Full Text] [Related]
17. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078 [TBL] [Abstract][Full Text] [Related]
18. General surgical complications in heart and heart-lung transplantation. Steed DL; Brown B; Reilly JJ; Peitzman AB; Griffith BP; Hardesty RL; Webster MW Surgery; 1985 Oct; 98(4):739-45. PubMed ID: 3931274 [TBL] [Abstract][Full Text] [Related]
19. Diastolic dysfunction coincides with early mild transplant rejection: in situ measurements in a heterotopic rat heart transplant model. Yoshida S; Takeuchi K; del Nido PJ; Ho C J Heart Lung Transplant; 1998 Nov; 17(11):1049-56. PubMed ID: 9855443 [TBL] [Abstract][Full Text] [Related]
20. The characteristic histological changes associated with rejection in heart-lung transplant recipients. Hutter JA; Stewart S; Higenbottam T; Scott JP; Wallwork J Transplant Proc; 1989 Feb; 21(1 Pt 1):435-6. PubMed ID: 2495610 [No Abstract] [Full Text] [Related] [Next] [New Search]